Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HUC-MSCs in Primary Ovarian Insufficiency
NCT03033277Phase 2Unknown
- Sponsor
- Chinese Academy of Sciences
- Start
- Feb 2016
- Primary completion
- Apr 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord derived mesenchymal stem cells in primary ovarian insufficiency (POI), sponsored by Chinese Academy of Sciences. Status: unknown.
02
Drugs
human umbilical cord derived mesenchymal stem cells
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT03033277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03033277.